News file for: Vaccine
Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea’s SK Chemicals for the development of pneumococcal conjugate vaccine.
Japan’s Global Health Initiative Technology Fund has committed US$12 million in grants for neglected diseases and a potential tuberculosis vaccine.
By linking Queensland records of HPV vaccinations with the pap smear register, scientists have been able to show that vaccinations have been effective in protecting against cervical cancer.
China has made great strides in improving its ability to handle a public health emergency, but problems still linger in disease reporting, writes Dr. Yanzhong Huang.
Sinovac Biotech has submitted a clinical trial application to commence clinical trials for its vaccine Avian influenza A (H7N9) vaccine.
Takeda has announced a sales agreement with BIKEN to commence the sale of BIKEN’s chickenpox vaccine in Japan from February 2014.
A project to introduce mosquitoes that could potentially block dengue virus on an island off Vietnam has run into an early hurdle.
Lotus Pharmaceutical has signed a deal with US-based drug maker Alvogen Group Inc, allowing Alvogen to acquire 60 percent of its shares.
Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.
In the past decade of intensive farming industrialization, a deluge of viral diseases has threatened public health, writes Zaria Gorvett.